Lotte Holm Land - Institute of Clinical Research, University of Southern Denmark

基本信息

浏览量：7

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

3531: the NARLAL II Trial: First Results on Loco-Regional Control in Stage 3 NSCLC

Tine Schytte,Charlotte Kristiansen,Ane Appelt,Azza Khalil, Carsten Brink,Christina Maria Lutz, Ditte Slot Moeller, Erland Sande, Filippa Sundbye,Gitte Persson,Lone Hoffmann,Lotte Holm Land,Lotte Victoria Rogg,Mette Poehl, Mikkel Lund, Morten Nielsen,Nina Levin, olfred Hansen,Rune Slot Thing, Tarje Halvorsen, Tine Bjoern Nielsen, Torben Schjødt Hansen, Vilde Haakensen,Wiviann Ottosson,Marianne Knap

Radiotherapy and Oncology (2024)

引用0浏览0引用

Value of 2-[ 18 F]FDG-PET/CT in Identifying Immune-Related Adverse Events in Patients with Melanoma or Non-Small Cell Lung Cancer: a Systematic Scoping Review

Sambavy Nadaraja, Jonas Helsing, Mohammad Naghavi-Bezhad,Lotte H. Land,Christina H. Ruhlmann,Oke Gerke,Malene G. Hildebrandt

Clinical and translational imaging/Clinical and Translational Imagingno. 2 (2024): 187-195

引用0浏览0引用

Value of 2-[¹⁸F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review

Sambavy Nadaraja, Jonas Helsing, Mohammad Naghavi-Bezhad,Lotte H. Land,Christina H. Ruhlmann,Oke Gerke,Malene G. Hildebrandt

CLINICAL AND TRANSLATIONAL IMAGINGno. 2 (2024): 187-195

引用0浏览0引用

PD-0668 Hypo- Vs. Standard Fractionated Radiotherapy in Inoperable NSCLC Not Candidate for Chemo-Radiation

O. Hansen,T. Schytte,L. H. Land,T. B. Nielsen,M. Nielsen

Radiotherapy and Oncology（2022）

引用0浏览0引用

Surveillance with FDG PET/CT after Completion of Therapy for NSCLC: A Status Update on Inclusion in the SUPE_R Trial

K. Guldbrandsen,K. Skougaard,T. R. Rasmussen, B. Sorensen,L. S. Mortensen,Z. Saghir,S. Borissova,G. Persson,H. Skuladottir, S. Thisaruban,U. Bodtger, S. H. Schwaner,L. H. Land,O. Gerke,C. B. Laursen,L. B. Ahlborn,M. Pohl, C. N. Meyer, J. Ehlers, M. S. Christophersen,C. Kristiansen,O. Hilberg, B. A. Rychwicka-Kielek,T. McCulloch,B. M. Fischer

Journal of Thoracic Oncology（2022）

引用0浏览0引用

EP01.07-001 Surveillance with FDG PET/CT after Completion of Therapy for NSCLC: A Status Update on Inclusion in the SUPE_R Trial

K. Guldbrandsen,K. Skougaard,T.R. Rasmussen, B. Sørensen,L.S. Mortensen,Z. Saghir,S. Borissova,G. Persson,H. Skuladottir, S. Thisaruban,U. Bødtger, S.H. Schwaner,L.H. Land,O. Gerke,C.B. Laursen,L.B. Ahlborn,M. Pøhl, C.N. Meyer, J. Ehlers, M.S. Christophersen

Journal of thoracic oncology（2022）

引用0浏览0引用

P17.02 Durvalumab after Chemoradiotherapy (DART) for NSCLC Patients – a Phase II Translational and Biomarker Study

V. D. Haakensen,H. Horndalsveen, H. M. Nymoen,G. Holgersson,L. Holm Land,J. Koivunen,S. Cicenas,K. Oselin, T. Madebo,R. Van Helvoirt,N. Helbekkmo,B. H. Gronberg, M. Aanerud, L. Rogg,A. Helland

Journal of thoracic oncology（2021）

引用1浏览0引用

Influence of specific comorbidities on survival after early-stage breast cancer

Marianne Ewertz,Lotte Holm Land,Susanne Oksbjerg Dalton,Deirdre Cronin-Fenton, Maj-Britt Jensen

Acta oncologica (Stockholm, Sweden)（2018）

引用43浏览0WOS引用

Treatment Decision Making after Introduction of PD-L1 Reflex Testing in NSCLC Up Front

Karin Holmskov Hansen,Lotte Holm Land,Tine Schytte

Journal of clinical oncology（2018）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn